Answers are grounded in this paper and cite their sources.
This review examines the relationship between the gut microbiome and Alzheimer's disease (AD). We found evidence that the gut microbiota may play a role in the pathogenesis of AD through inflammation and metabolite production. Early intervention strategies based on modulation of the gut microbiota could improve symptoms. Gut dysbiosis, inflammation, and the NLRP3 inflammasome appear to be involved in the disease. Modifying the gut microbiota with probiotics, prebiotics and dietary changes could have beneficial effects in AD, according to animal and human studies. More research is needed to understand the mechanisms and to evaluate the efficacy of these interventions in clinical trials. In conclusion, modification of the gut microbiome could be an effective therapeutic strategy for AD, but more research is needed for clinical implementation.
No takes yet. Share an insight, caveat, or question.
Bedon et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: